149 related articles for article (PubMed ID: 36356492)
1. Comparison of discrimination performance of 11 lung cancer risk models for predicting lung cancer in a prospective cohort of screening-age adults from Germany followed over 17 years.
Bhardwaj M; Schöttker B; Holleczek B; Brenner H
Lung Cancer; 2022 Dec; 174():83-90. PubMed ID: 36356492
[TBL] [Abstract][Full Text] [Related]
2. Implications of Nine Risk Prediction Models for Selecting Ever-Smokers for Computed Tomography Lung Cancer Screening.
Katki HA; Kovalchik SA; Petito LC; Cheung LC; Jacobs E; Jemal A; Berg CD; Chaturvedi AK
Ann Intern Med; 2018 Jul; 169(1):10-19. PubMed ID: 29800127
[TBL] [Abstract][Full Text] [Related]
3. Low positive predictive value of computed tomography screening for lung cancer irrespective of commonly employed definitions of target population.
Krilaviciute A; Brenner H
Int J Cancer; 2021 Jul; 149(1):58-65. PubMed ID: 33634860
[TBL] [Abstract][Full Text] [Related]
4. Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial.
Becker N; Motsch E; Trotter A; Heussel CP; Dienemann H; Schnabel PA; Kauczor HU; Maldonado SG; Miller AB; Kaaks R; Delorme S
Int J Cancer; 2020 Mar; 146(6):1503-1513. PubMed ID: 31162856
[TBL] [Abstract][Full Text] [Related]
5. Risk prediction models versus simplified selection criteria to determine eligibility for lung cancer screening: an analysis of German federal-wide survey and incidence data.
Hüsing A; Kaaks R
Eur J Epidemiol; 2020 Oct; 35(10):899-912. PubMed ID: 32594286
[TBL] [Abstract][Full Text] [Related]
6. Baseline computed tomography screening and blood microRNA predict lung cancer risk and define adequate intervals in the BioMILD trial.
Pastorino U; Boeri M; Sestini S; Sabia F; Milanese G; Silva M; Suatoni P; Verri C; Cantarutti A; Sverzellati N; Corrao G; Marchianò A; Sozzi G
Ann Oncol; 2022 Apr; 33(4):395-405. PubMed ID: 35091076
[TBL] [Abstract][Full Text] [Related]
7. Individual and joint contributions of genetic and methylation risk scores for enhancing lung cancer risk stratification: data from a population-based cohort in Germany.
Yu H; Raut JR; Schöttker B; Holleczek B; Zhang Y; Brenner H
Clin Epigenetics; 2020 Jun; 12(1):89. PubMed ID: 32552915
[TBL] [Abstract][Full Text] [Related]
8. Deep Learning Using Chest Radiographs to Identify High-Risk Smokers for Lung Cancer Screening Computed Tomography: Development and Validation of a Prediction Model.
Lu MT; Raghu VK; Mayrhofer T; Aerts HJWL; Hoffmann U
Ann Intern Med; 2020 Nov; 173(9):704-713. PubMed ID: 32866413
[TBL] [Abstract][Full Text] [Related]
9. Selecting High-Risk Individuals for Lung Cancer Screening: A Prospective Evaluation of Existing Risk Models and Eligibility Criteria in the German EPIC Cohort.
Li K; Hüsing A; Sookthai D; Bergmann M; Boeing H; Becker N; Kaaks R
Cancer Prev Res (Phila); 2015 Sep; 8(9):777-85. PubMed ID: 26076698
[TBL] [Abstract][Full Text] [Related]
10. Potential of Inflammatory Protein Signatures for Enhanced Selection of People for Lung Cancer Screening.
Bhardwaj M; Schöttker B; Holleczek B; Benner A; Schrotz-King P; Brenner H
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565275
[TBL] [Abstract][Full Text] [Related]
11. Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial.
Paci E; Puliti D; Lopes Pegna A; Carrozzi L; Picozzi G; Falaschi F; Pistelli F; Aquilini F; Ocello C; Zappa M; Carozzi FM; Mascalchi M;
Thorax; 2017 Sep; 72(9):825-831. PubMed ID: 28377492
[TBL] [Abstract][Full Text] [Related]
12. Role of Low-Dose Computerized Tomography in Lung Cancer Screening among Never-Smokers.
Kang HR; Cho JY; Lee SH; Lee YJ; Park JS; Cho YJ; Yoon HI; Lee KW; Lee JH; Lee CT
J Thorac Oncol; 2019 Mar; 14(3):436-444. PubMed ID: 30445189
[TBL] [Abstract][Full Text] [Related]
13. Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study.
Ten Haaf K; Jeon J; Tammemägi MC; Han SS; Kong CY; Plevritis SK; Feuer EJ; de Koning HJ; Steyerberg EW; Meza R
PLoS Med; 2017 Apr; 14(4):e1002277. PubMed ID: 28376113
[TBL] [Abstract][Full Text] [Related]
14. Systematic review of the cost-effectiveness of screening for lung cancer with low dose computed tomography.
Grover H; King W; Bhattarai N; Moloney E; Sharp L; Fuller L
Lung Cancer; 2022 Aug; 170():20-33. PubMed ID: 35700629
[TBL] [Abstract][Full Text] [Related]
15. One-off low-dose CT for lung cancer screening in China: a multicentre, population-based, prospective cohort study.
Li N; Tan F; Chen W; Dai M; Wang F; Shen S; Tang W; Li J; Yu Y; Cao W; Xu Y; Qin C; Zhao L; Zhu M; Guo L; Wu Z; Yang Z; Zheng Y; Chen H; Liu Y; Wei D; Dong D; Cao J; Zhang S; Yan S; Wang N; Du L; Shen H; Wu N; He J;
Lancet Respir Med; 2022 Apr; 10(4):378-391. PubMed ID: 35276087
[TBL] [Abstract][Full Text] [Related]
16. Disparity in Lung Cancer Screening Among Smokers and Nonsmokers in China: Prospective Cohort Study.
Wang L; Wang Y; Wang F; Gao Y; Fang Z; Gong W; Li H; Zhu C; Chen Y; Shi L; Du L; Li N
JMIR Public Health Surveill; 2023 Mar; 9():e43586. PubMed ID: 36917151
[TBL] [Abstract][Full Text] [Related]
17. OWL: an optimized and independently validated machine learning prediction model for lung cancer screening based on the UK Biobank, PLCO, and NLST populations.
Pan Z; Zhang R; Shen S; Lin Y; Zhang L; Wang X; Ye Q; Wang X; Chen J; Zhao Y; Christiani DC; Li Y; Chen F; Wei Y
EBioMedicine; 2023 Feb; 88():104443. PubMed ID: 36701900
[TBL] [Abstract][Full Text] [Related]
18. Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom.
Robbins HA; Alcala K; Swerdlow AJ; Schoemaker MJ; Wareham N; Travis RC; Crosbie PAJ; Callister M; Baldwin DR; Landy R; Johansson M
Br J Cancer; 2021 Jun; 124(12):2026-2034. PubMed ID: 33846525
[TBL] [Abstract][Full Text] [Related]
19. Low-Dose Computed Tomography Screening in Relatives With a Family History of Lung Cancer.
Wang CL; Hsu KH; Chang YH; Ho CC; Chiang CJ; Chen KC; Cheung YC; Huang PC; Chen YR; Chen CY; Hsu CP; Hsia JY; Chen HY; Yang SY; Li YJ; Yang TY; Tseng JS; Chuang CY; Hsiung CA; Chen YM; Huang MS; Yu CJ; Chen KY; Su WC; Chen JJW; Yu SL; Chen CJ; Yang PC; Tsai YH; Chang GC
J Thorac Oncol; 2023 Nov; 18(11):1492-1503. PubMed ID: 37414358
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
